Testimonials

What clients are saying about us.

A professional provider will ensure the quality
”It is great that a professional provider will ensure the quality in these new and
Read More
Professor Torben F. Ørntoft, Dept. of Molecular Medicine (MOMA),
”It is great that a professional provider will ensure the quality in these new and competence demanding analyses. Mogens has many years of experience from collaborations with the pharmaceutical industry under GLP-demands, and I am sure that this is a guarantee of competences and quality.”
A professional provider will ensure the quality
Professor Torben F. Ørntoft, Dept. of Molecular Medicine (MOMA),
Analysis of blood and urine to identify novel biomarkers
“Current research deals intensively with analysis of blood and urine to identify novel biomarkers .
Read More
Professor. Lars Dyrskjøt Andersen, Dept. of Molecular Medicine (MOMA),
“Current research deals intensively with analysis of blood and urine to identify novel biomarkers. One of the challenges is to develop sensitive and specific methods to identify disease-associated molecules in complex clinical samples. I am convinced that the new sensitive methods for measuring biomarker signatures will become an important tool in biomarker research."
Analysis of blood and urine to identify novel biomarkers
Professor. Lars Dyrskjøt Andersen, Dept. of Molecular Medicine (MOMA),
BioXpedia delivered with care and precision
“BioXpedia has been dedicated to help me achieve my research goals and move forward .
Read More
Meg Duroux, Associate Professor, Laboratory for Cancer Biology, Biomedicine,
“BioXpedia has been dedicated to help me achieve my research goals and move forward. The staff are friendly, competent, efficient and eager to make sure that all flows smoothly to obtain the best possible solution and results. I would strongly recommend to anybody wanting to have quality results, delivered with care and precision.”
BioXpedia delivered with care and precision
Meg Duroux, Associate Professor, Laboratory for Cancer Biology, Biomedicine,
Overview of the identification process to find disease markers
”We are used to measuring 1-2 relations at a time, while this type of
Read More
Professor, Kristian Stengaard-Pedersen, Dept of Rheumatology,
”We are used to measuring 1-2 relations at a time, while this type of panels make it possible to broaden the analysis, so that we at one time fast and precisely may measure the content of several substances and proteins in a biopsy. If this screening method holds its promise, it is fantastic. It might turn out to be of huge importance to guiding us and giving an overview of the identification process to find disease markers.”
Overview of the identification process to find disease markers
Professor, Kristian Stengaard-Pedersen, Dept of Rheumatology,
Quality data was delivered without delay
“Gene expression analysis of formalin fixed tissue is challenging . We collaborated with BioXpedia on
Read More
Lauge Hjort Mikkelsen, MD, Ph.D. fellow, Department of Pathology,
“Gene expression analysis of formalin fixed tissue is challenging. We collaborated with BioXpedia on analysing gene expression levels of known cancer genes in rare mucosal melanomas using NanoString technology. The BioXpedia staff was highly helpful and competent in this process, and they assisted in designing and performing the study optimally with their dedicated work. The handling of specimens was careful, and quality data was delivered without delay. Furthermore, BioXpedia helped with analysing the data, and this service was highly appreciated. I was very grateful for our collaboration and I would strongly recommend BioXpedia to all other working within the field of molecular biology in cancer .”
Quality data was delivered without delay
Lauge Hjort Mikkelsen, MD, Ph.D. fellow, Department of Pathology,
Targeted biomarker analysis
”Immunotherapy is currently a popular and effective method for treating lung cancer . Unfortunately,
Read More
Henrik Hager, Pathologist and Clinical Associate Professor,
Center of Clinical Pathology at Vejle Hospital
”Immunotherapy is currently a popular and effective method for treating lung cancer. Unfortunately, it can be difficult to follow the effect of the treatment, especially in the beginning, where the tumour progression cannot be monitored using x-ray as with traditional chemotherapy and radiation therapy. Thus, we are searching for valid and suitable clinical biomarkers, that will allow us to non-invasively monitor the effect of the treatment i.e. in blood and bronchial secretions. These new protein screening panels have an enormous potential, as targeted biomarker analysis will enable us to perform broad analyses of immune proteins and monitor how the treatment affects their up and down regulation.”
Targeted biomarker analysis
Henrik Hager, Pathologist and Clinical Associate Professor,
Center of Clinical Pathology at Vejle Hospital
The BioXpedia team quickly found a solution
”During my Ph .D project my supervisor drew my attention to BioXpedia ’s services .
Read More
Mia Klinkvort Kempel, Cand. med., Department of Occupational Medicine,
Regional Hospital West Jutland
”During my Ph.D project my supervisor drew my attention to BioXpedia’s services. Especially interesting for me was the biomarker screening using the Olink Proteomics platform, and I quickly realized it could benefit my research substantially by enabling a more comprehensive analysis of my samples. The panels available did not include assays for all the biomarkers I wanted to analyze, however, the BioXpedia team quickly found a solution allowing for a complete analysis of all biomarkers – and they thoroughly instructed me in the sample preparation process. I have experienced a very positive cooperation with a high degree of kindness, professionalism and flexibility, and I look forward to my future cooperation with the BioXpedia team.”
The BioXpedia team quickly found a solution
Mia Klinkvort Kempel, Cand. med., Department of Occupational Medicine,
Regional Hospital West Jutland

Lets start a new project!